We are live on ! Find out more
P

&Partners Portfolio holdings

AUM $20.2B
1-Year Est. Return 19.79%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+19.79%
3 Year Est. Return
+62.7%
5 Year Est. Return
+67.16%
10 Year Est. Return
AUM
$13B
AUM Growth
+$3.62B
Cap. Flow
+$2.76B
Cap. Flow %
21.17%
Top 10 Hldgs %
22.9%
Holding
2,054
New
301
Increased
1,315
Reduced
342
Closed
62

Sector Composition

Rank Sector Weight
1 Technology 17.48%
2 Financials 9.37%
3 Healthcare 6.07%
4 Industrials 5.62%
5 Consumer Discretionary 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCSF icon
1326
Bain Capital Specialty
BCSF
$802M
$532K ﹤0.01%
35,379
+2,907
+9% +$44.3K
VLUE icon
1327
iShares MSCI USA Value Factor ETF
VLUE
$9.4B
$531K ﹤0.01%
4,693
+228
+5% +$24.1K
MTH icon
1328
Meritage Homes
MTH
$4.87B
$529K ﹤0.01%
7,937
+2,104
+36% +$139K
VLTO icon
1329
Veralto
VLTO
$22.6B
$528K ﹤0.01%
5,233
+1,514
+41% +$146K
BBWI icon
1330
Bath & Body Works
BBWI
$4.01B
$527K ﹤0.01%
+17,610
New +$515K
POST icon
1331
Post Holdings
POST
$4.12B
$526K ﹤0.01%
4,812
-111
-2% -$12.4K
SNEX icon
1332
StoneX
SNEX
$8.83B
$526K ﹤0.01%
12,899
-342
-3% -$12.9K
RNR icon
1333
RenaissanceRe
RNR
$13.7B
$524K ﹤0.01%
2,156
+704
+48% +$171K
KE
1334
Kimball Electronics
KE
$598M
$523K ﹤0.01%
27,197
+5,344
+24% +$89.5K
FSLR icon
1335
First Solar
FSLR
$21.8B
$522K ﹤0.01%
3,149
+688
+28% +$102K
TCAF icon
1336
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$7.81B
$521K ﹤0.01%
14,754
+1,580
+12% +$51.8K
UTHR icon
1337
United Therapeutics
UTHR
$26.3B
$520K ﹤0.01%
1,807
+32
+2% +$9.56K
USPH icon
1338
US Physical Therapy
USPH
$1.14B
$519K ﹤0.01%
6,639
+3,352
+102% +$247K
JAZZ icon
1339
Jazz Pharmaceuticals
JAZZ
$15.9B
$517K ﹤0.01%
4,877
+872
+22% +$94.7K
SCHI icon
1340
Schwab 5-10 Year Corporate Bond ETF
SCHI
$11.4B
$517K ﹤0.01%
22,712
+324
+1% +$7.23K
EMN icon
1341
Eastman Chemical
EMN
$7.8B
$517K ﹤0.01%
7,455
-699
-9% -$54.9K
STBA icon
1342
S&T Bancorp
STBA
$1.86B
$514K ﹤0.01%
13,687
+1,276
+10% +$46.6K
NIE
1343
Virtus Equity & Convertible Income Fund
NIE
$718M
$513K ﹤0.01%
+21,446
New +$480K
SFM icon
1344
Sprouts Farmers Market
SFM
$7.04B
$512K ﹤0.01%
3,112
+1,474
+90% +$241K
UNF icon
1345
Unifirst Corp
UNF
$5.32B
$512K ﹤0.01%
2,729
+851
+45% +$154K
TTEK icon
1346
Tetra Tech
TTEK
$8.23B
$512K ﹤0.01%
14,211
+4,500
+46% +$150K
DFIS icon
1347
Dimensional International Small Cap ETF
DFIS
$5.76B
$510K ﹤0.01%
17,085
+1,624
+11% +$44.9K
CXW icon
1348
CoreCivic
CXW
$3.1B
$510K ﹤0.01%
24,182
-2,589
-10% -$55.8K
ARDC
1349
Are Dynamic Credit Allocation Fund
ARDC
$297M
$509K ﹤0.01%
+35,792
New +$494K
RHP icon
1350
Ryman Hospitality Properties
RHP
$8.4B
$508K ﹤0.01%
+5,149
New +$481K

Similar funds

&Partners's Q2 2025 Portfolio in Review

As of Q2 2025, &Partners held 2,054 positions worth $13B, up 38% from $9.41B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

&Partners deployed $2.76B of net new capital in Q2 2025, opening 301 new positions and adding to 1,315 existing holdings. Its largest new stake was GMO US Quality ETF: 259,884 shares worth $8.98M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Analog Devices, an estimated $16.1M trimmed.

  • &Partners's largest Q2 2025 buy was GMO US Quality ETF: 259,884 shares worth $8.98M.
  • &Partners added most to Microsoft in Q2 2025, an estimated $96.6M increase.
  • &Partners's biggest Q2 2025 reduction was Analog Devices, cutting an estimated $16.1M.
  • &Partners fully exited Vanguard US Multifactor ETF in Q2 2025, selling an estimated $1.6M.
  • &Partners's ten largest holdings make up 23% of its $13B portfolio in Q2 2025.
  • &Partners opened 301 new positions and closed 62 in Q2 2025.
  • &Partners's portfolio value rose 38% quarter-over-quarter to $13B.

Based on &Partners's 13F filing for Q2 2025, filed 14 Aug 2025.